Search

Author/Creator Newman, Robby

1. Enhanced efficacy of ALT-803, an IL-15-based superagonist complex, in combination with immune checkpoint inhibitors in an orthotopic muscle invasive bladder tumor model in mice. (4th November 2015)

Authors:
Xu, Wenxin; Kage, Karen; Marcus, Warren D; Newman, Robby; Alter, Sarah; Rhode, Peter R; Wong, Hing C
Journal:
Journal for immunotherapy of cancer
Issue:
Volume 3(2015)Supplement 2
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. Enhanced efficacy of ALT-803, an IL-15-based superagonist complex, in combination with immune checkpoint inhibitors in an orthotopic muscle invasive bladder tumor model in mice. Issue 2 (December 2015)

Authors:
Xu, Wenxin; Kage, Karen; Marcus, Warren; Newman, Robby; Alter, Sarah; Rhode, Peter; Wong, Hing
Journal:
Journal for immunotherapy of cancer
Issue:
Volume 3:Issue 2(2015)
Page Start:
1
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. The multi-functionality of N-809, a novel fusion protein encompassing anti-PD-L1 and the IL-15 superagonist fusion complex. (1st February 2019)

Authors:
Jochems, Caroline; Tritsch, Sarah R.; Knudson, Karin M.; Gameiro, Sofia R.; Rumfield, Claire Smalley; Pellom, Samuel T.; Morillon, Y. Maurice; Newman, Robby; Marcus, Warren; Szeto, Christopher; Rabizadeh, Shahrooz; Wong, Hing C.; Soon-Shiong, Patrick; Schlom, Jeffrey
Journal:
Oncoimmunology
Issue:
Volume 8:Number 2(2019)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗